204 related articles for article (PubMed ID: 30071789)
1. Five-year results after collagenase treatment of Dupuytren disease.
Werlinrud JC; Hansen KL; Larsen S; Lauritsen J
J Hand Surg Eur Vol; 2018 Oct; 43(8):841-847. PubMed ID: 30071789
[TBL] [Abstract][Full Text] [Related]
2. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
[TBL] [Abstract][Full Text] [Related]
3. Collagenase Tenotomy for Dupuytren Boutonniere.
Denkler KA; Vaughn CJ; Park KM; Hansen SL
Plast Reconstr Surg; 2021 Nov; 148(5):764e-768e. PubMed ID: 34705780
[TBL] [Abstract][Full Text] [Related]
4. Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands.
Nordenskjöld J; Lauritzson A; Åkesson A; Atroshi I
Acta Orthop; 2019 Dec; 90(6):517-522. PubMed ID: 31500473
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies.
Witthaut J; Jones G; Skrepnik N; Kushner H; Houston A; Lindau TR
J Hand Surg Am; 2013 Jan; 38(1):2-11. PubMed ID: 23218556
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.
Coleman S; Gilpin D; Kaplan FT; Houston A; Kaufman GJ; Cohen BM; Jones N; Tursi JP
J Hand Surg Am; 2014 Jan; 39(1):57-64. PubMed ID: 24315486
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Badalamente MA; Hurst LC; Benhaim P; Cohen BM
J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results.
Van Beeck A; Van den Broek M; Michielsen M; Didden K; Vuylsteke K; Verstreken F
Hand Surg Rehabil; 2017 Oct; 36(5):346-349. PubMed ID: 28732844
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren's Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up.
Abe Y
Plast Reconstr Surg; 2020 Jun; 145(6):1464-1474. PubMed ID: 32459776
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum.
Bear BJ; Peimer CA; Kaplan FTD; Kaufman GJ; Tursi JP; Smith T
J Hand Surg Am; 2017 May; 42(5):391.e1-391.e8. PubMed ID: 28341067
[TBL] [Abstract][Full Text] [Related]
11. Salvage palmar fasciectomy after initial treatment with collagenase clostridium histolyticum.
Eberlin KR; Kobraei EM; Nyame TT; Bloom JM; Upton J
Plast Reconstr Surg; 2015 Jun; 135(6):1000e-1006e. PubMed ID: 26017606
[TBL] [Abstract][Full Text] [Related]
12. Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial.
Skov ST; Bisgaard T; Søndergaard P; Lange J
J Hand Surg Am; 2017 May; 42(5):321-328.e3. PubMed ID: 28473158
[TBL] [Abstract][Full Text] [Related]
13. The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study.
Gaston RG; Larsen SE; Pess GM; Coleman S; Dean B; Cohen BM; Kaufman GJ; Tursi JP; Hurst LC
J Hand Surg Am; 2015 Oct; 40(10):1963-71. PubMed ID: 26216077
[TBL] [Abstract][Full Text] [Related]
14. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T
J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951
[TBL] [Abstract][Full Text] [Related]
15. Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study.
Zhou C; Hovius SER; Slijper HP; Feitz R; Van Nieuwenhoven CA; Pieters AJ; Selles RW
Plast Reconstr Surg; 2015 Jul; 136(1):87-97. PubMed ID: 25829153
[TBL] [Abstract][Full Text] [Related]
16. Collagenase Clostridium Histolyticum Injection for Dupuytren Contracture: 2-Year Follow-up.
Nayar SK; Pfisterer D; Ingari JV
Clin Orthop Surg; 2019 Sep; 11(3):332-336. PubMed ID: 31475055
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous Needle Fasciotomy Versus Collagenase Treatment for Dupuytren Contracture: A Randomized Controlled Trial with a Two-Year Follow-up.
Strömberg J; Ibsen Sörensen A; Fridén J
J Bone Joint Surg Am; 2018 Jul; 100(13):1079-1086. PubMed ID: 29975270
[TBL] [Abstract][Full Text] [Related]
18. Clostridium histolyticum as first-line treatment of Dupuytren's disease.
Hartig-Andreasen C; Schroll L; Lange J
Dan Med J; 2019 Feb; 66(2):. PubMed ID: 30722822
[TBL] [Abstract][Full Text] [Related]
19. The Use of Residual Collagenase for Single Digits With Multiple-Joint Dupuytren Contractures.
Grandizio LC; Akoon A; Heimbach J; Graham J; Klena JC
J Hand Surg Am; 2017 Jun; 42(6):472.e1-472.e6. PubMed ID: 28389081
[TBL] [Abstract][Full Text] [Related]
20. A
Pess GM; Sundbom M; Wilson K; Lindqvist D; Dahlin LB
J Plast Surg Hand Surg; 2018 Oct; 52(5):301-306. PubMed ID: 30039732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]